The research team, led by scientists at Guangxi Medical University and the Guangxi Academy of Sciences, prepared an ethyl acetate extract of perilla leaves, a fraction enriched for the plant’s flavonoids and other secondary metabolites. Perilla frutescens is classified in China as a traditional medicine and food homologous plant, meaning it occupies the unusual dual status of being both a therapeutic agent and an everyday ingredient. Its leaves are packed with antioxidant compounds, and previous work has catalogued an impressive chemical repertoire including rosmarinic acid, luteolin, apigenin, and various terpenoids. What remained unclear was whether these compounds could meaningfully influence the biology of aging, and if so, by what mechanism.

To answer that question, the researchers turned to C. elegans, a nematode worm about one millimeter long that shares a startling degree of genetic conservation with humans. Many of the genes that control longevity in worms, including the insulin/IGF-1 signaling pathway at the heart of this study, have direct counterparts in human cells. Because worms live only a few weeks, age rapidly, and can be manipulated genetically with precision, they allow researchers to test lifespan interventions that would take decades to evaluate in mammals. When the worms were fed the perilla extract, the results were striking: their lifespans were significantly prolonged compared with untreated controls.

Longevity alone is not necessarily desirable if the extra time is spent in frailty, so the team also measured healthspan markers. Treated worms showed enhanced pharyngeal pumping, the rhythmic contraction that drives feeding and serves as a proxy for neuromuscular vitality, as well as increased head thrashing frequency, a measure of motility and muscular vigor. Both metrics suggest that the extract did not merely keep the worms alive longer but preserved their functional capacity into old age. The animals also accumulated less lipofuscin, the pigment-rich cellular debris that builds up in aging tissues and is widely used as a microscopic clock of biological age in these organisms.

A central thread of the study concerns oxidative stress, one of the canonical hallmarks of aging. Reactive oxygen species, or ROS, are chemically reactive molecules generated as byproducts of metabolism that can damage DNA, proteins, and lipids. Aging organisms lose the ability to neutralize these molecules efficiently, and the resulting damage accumulates over time. In the treated worms, ROS levels dropped markedly, and the activity of antioxidant enzymes rose. The researchers also measured malondialdehyde, or MDA, a well-established marker of lipid peroxidation, essentially the chemical rancidity of cell membranes, and found it reduced following extract treatment.

The worms’ stress resilience extended beyond their internal chemistry. When exposed to elevated temperatures, perilla-treated nematodes survived better than controls, indicating enhanced thermotolerance. They also withstood exposure to juglone, a compound deliberately used in the laboratory to induce severe oxidative stress. This dual protection against heat and chemical insult suggests that the extract activates a broad, coordinated stress-response program rather than a narrow defense against a single threat. In the language of biogerontology, the extract behaves like a nutritional hormetin, a mild stressor or bioactive compound that triggers adaptive, protective responses that ultimately benefit the organism, echoing the principle of hormesis in which a little stress makes the system stronger.

Perhaps the most visually dramatic finding involved fat. The treated worms stored markedly less lipid than their untreated counterparts, pointing to a genuine lipid-lowering effect. Fat metabolism and longevity are deeply intertwined in C. elegans, where lipid droplets serve not only as energy reservoirs but also as signaling hubs that influence aging. The interplay is complex, since some lipid species protect against age-related decline while excess storage is associated with shorter lifespans and metabolic dysfunction. The finding that a plant extract can reprogram lipid metabolism while simultaneously extending life makes perilla an intriguing candidate for further investigation as a nutraceutical, a food-derived compound with medicinal properties.

Mechanistically, the study traced these effects to the insulin/IGF-1 signaling pathway, one of the most intensively studied longevity circuits in biology. In worms, reducing signaling through this pathway triggers a cascade that activates DAF-16, the worm ortholog of the FOXO family of transcription factors, which then translocates to the nucleus and switches on an army of protective genes. The researchers found that the perilla extract activated this pathway and upregulated both DAF-16/FOXO and SKN-1, the worm equivalent of the mammalian Nrf2 transcription factor that masterminds antioxidant defenses. Consistent with this activation, downstream stress-response genes including sod-3, which encodes a superoxide dismutase enzyme, gst-4, a glutathione S-transferase, and hsp-16.2, a heat shock protein, all showed increased expression.

The upregulation of glutathione-related machinery is particularly noteworthy. Glutathione is the cell’s principal endogenous antioxidant, a tripeptide that mops up reactive molecules and maintains the cellular redox balance, and its depletion is implicated in aging and neurodegenerative disease. By enhancing glutathione metabolism alongside the DAF-16 and SKN-1 programs, the extract appears to reinforce the worm’s antioxidant architecture at multiple levels simultaneously. The authors also observed a reprogramming of lipid metabolism, suggesting that the extract coordinates metabolic and stress-response systems rather than acting on a single target, a multicomponent mode of action consistent with the behavior of complex botanical extracts rich in flavonoids and terpenoids.

The findings position perilla leaf extract as a promising candidate in the growing field of nutritional interventions against aging, though important caveats remain. The work was conducted entirely in nematodes, and many compounds that extend worm lifespan fail to translate to mammals, let alone humans. Dosing, bioavailability, and the identity of the specific active molecules within the extract all require further study. Nevertheless, the convergence of extended lifespan, improved physical function, reduced fat accumulation, and a clearly defined molecular mechanism centered on the insulin/IGF-1 pathway, DAF-16, and SKN-1 gives the results unusual coherence for a botanical study. As the search for safe, food-derived compounds that promote healthy aging intensifies, the leafy green herb on the sushi plate has earned a place in the conversation.

Subject of Research: Lifespan extension and lipid-lowering effects of Perilla frutescens leaf extract via insulin/IGF-1 signaling in Caenorhabditis elegans

Article Title: Perilla frutescens extract reduces fat accumulation and promotes longevity in Caenorhabditis elegans via modulation of the insulin/IGF-1 signaling pathway

Article References: Huang, L., Yin, F., Fu, X., Huang, Y., Tang, Y., Liao, G., Wang, B., Yang, T., Huang, G., & Chen, X. (2026). Perilla frutescens extract reduces fat accumulation and promotes longevity in Caenorhabditis elegans via modulation of the insulin/IGF-1 signaling pathway. Biogerontology, 27(5), Article 168. https://doi.org/10.1007/s10522-026-10507-z

Image Credits: AI Generated

DOI: 10.1007/s10522-026-10507-z

Keywords: Perilla frutescens, Caenorhabditis elegans, lifespan extension, insulin/IGF-1 signaling, DAF-16/FOXO, SKN-1/Nrf2, oxidative stress, lipid metabolism, flavonoids, hormesis, nutraceutical, biogerontology

The Gini coefficient takes a value between zero and one. In economics, a value of zero would mean everyone earns exactly the same income, while a value approaching one means a single individual holds nearly all the wealth. The researchers reasoned that the same logic applies to metabolite concentrations measured across a population of samples. If a molecule is homeostatically regulated by cells, tissues, or the organism as a whole, its concentration should be similar from person to person, yielding a low Gini coefficient. Conversely, a molecule that is exogenous, such as a pharmaceutical drug that only some individuals have ingested, should show wildly unequal concentrations across a cohort, producing a Gini coefficient close to one.

To test this idea, the team mined publicly available metabolomics datasets, including a large study of more than 200 identified plasma metabolites measured in 1,125 individuals with chronic obstructive pulmonary disease, available through the Metabolomics Workbench. The results were striking. Endogenous metabolites, which the authors call endogenites, peaked in their Gini distribution at around 0.2, while exogenous molecules such as drugs and food-derived compounds peaked above 0.95. The median Gini coefficient across the entire dataset was 0.263. When the researchers classified molecules by origin, 73 percent of exogenous molecules had Gini coefficients above 0.5, compared with just 2.9 percent of molecules considered endogenous or regulated.

Among the most tightly controlled molecules were the amino acids. Essential and non-essential amino acids had identical average Gini coefficients of just 0.14, and nine of the 25 lowest Gini values in the dataset belonged to amino acids including methionine, arginine, proline, serine, phenylalanine, asparagine, tryptophan, lysine, and glutamine. Glutamine itself recorded the lowest value of all, a Gini coefficient of 0.066 with a 95 percent confidence interval of just 0.063 to 0.068, a figure even lower than any observed in the team’s earlier transcriptomics analyses. Given that glutamine is a major hub of nitrogen metabolism, such extreme uniformity makes biological sense and suggests the molecule could even serve as a normalisation standard in metabolomics studies where sample volumes are uncertain.

At the opposite extreme sat pharmaceutical compounds. The anticonvulsant lamotrigine, for example, posted a Gini coefficient of 0.99, meaning its presence in plasma was almost entirely confined to the small subset of participants taking the drug. In a second dataset of 681 serum metabolites from 340 individuals studied in the context of tuberculosis, the highest values belonged to metabolites of paracetamol and aspirin. The researchers also examined vitamins, which occupy an interesting middle ground: they are essential and therefore physiologically important, yet exogenous in origin. Their Gini coefficients fell in an intermediate range of roughly 0.2 to 0.4, consistent with partial regulation as cofactors, though the values varied more than threefold across vitamins, likely reflecting differences in diet, absorption, supplementation, and microbiome interactions.

The study’s second focus was ergothioneine, a sulfur-containing amino acid derivative with the formula C9H15N3O2S and an exact monoisotopic mass of 229.0885 Da. Humans cannot synthesise this compound; it comes entirely from the diet, most notably mushrooms, and is transported into tissues by a dedicated transporter. Growing evidence links higher ergothioneine levels to reduced risks of cardiovascular disease, cognitive decline, dementia, and frailty, and previous work by the same group showed that women with high plasma ergothioneine were far less likely to develop pre-eclampsia. Because ergothioneine is exogenous but clearly physiologically important, the team predicted it would show an intermediate Gini coefficient, and the data confirmed this. Across multiple independent studies, ergothioneine’s Gini coefficient clustered consistently between 0.3 and 0.4: 0.38 in the COPD dataset, 0.373 in the tuberculosis cohort, 0.325 in a whole-blood dementia study, 0.457 in an ageing study, and 0.37 to 0.4 in a large dementia cohort from Singapore.

The analytical chemistry behind these measurements is itself noteworthy. Ergothioneine’s protonated form has a mass-to-charge ratio of 230.0958 in positive electrospray ionisation mode, and no other biologically relevant molecule lies within even 10 parts per million of this value, making database searches for the compound unusually straightforward. In new experimental work reported in the paper, the team measured ergothioneine in 40 antenatal serum samples from a pilot study at Liverpool Women’s Hospital, using ultra-high performance liquid chromatography coupled to an Orbitrap Exploris 240 mass spectrometer at a resolution of 120,000, with calibration solutions spanning 0.01 to 500 micromolar.

The Liverpool pilot delivered two surprises. First, the median ergothioneine concentration was just 180 nanograms per millilitre, far below the 261 nanograms per millilitre median seen in the earlier SCOPE study of 432 pregnant women; in fact, 180 nanograms per millilitre corresponds only to the ninth percentile of the earlier cohort. Second, women who went on to develop pre-eclampsia did not show the expected lower ergothioneine levels. The authors suggest this apparent contradiction dissolves once the population’s very low baseline is recognised: when nearly everyone is deficient, the protective relationship with concentration is obscured. Intriguingly, the Gini coefficient in the Liverpool cohort was lower than in almost all other ergothioneine studies, hinting that a depressed Gini value, even without absolute concentrations, might flag a population with inadequate ergothioneine exposure and a likely need for supplementation.

The researchers propose rough interpretive thresholds: metabolites with Gini coefficients below about 0.25 are subject to significant homeostasis or show low variation in exogenous supply, while those above about 0.75 are likely exogenous and largely unregulated. Molecules in between, like most vitamins and the nutraceuticals ergothioneine and kynurenic acid, are probably exogenous but partially regulated. The authors caution that a high Gini coefficient could sometimes reflect analytical error, missing values, or variable pharmacokinetics, making the metric best viewed as hypothesis-generating. A low value, however, is hard to explain away, and reliably indicates tight biological control. The team also notes that urinary metabolomes did not show systematically higher Gini coefficients than plasma, and that applying the approach to gut microbiome-derived metabolites awaits raw data that are not yet publicly available.

Beyond its technical contribution, the work carries a broader message about health inequality. The Liverpool findings, with median ergothioneine levels sitting at the ninth percentile of a comparable cohort, echo documented patterns of socioeconomic disparity in British health and mortality statistics. If a simple statistic borrowed from economics can simultaneously identify which molecules the body defends, expose hidden dietary deficits, and strengthen the case for targeted nutritional intervention, the Gini coefficient may prove to be one of the most versatile imports metabolomics has ever received from the social sciences.

Subject of Research: Using the Gini coefficient as a surrogate measure of metabolite regulability and homeostasis, with a focus on the diet-derived antioxidant ergothioneine

Article Title: The Gini coefficient as a surrogate for the regulability or homeostasis of metabolite concentrations: focus on ergothioneine

Article References: Kell, D. B., Dunn, W. B., Winder, C. L., Anand, K., Greenfield, B., Kenny, L. C., Merriel, A., Moore, J. B., & Waitt, C. (2026). The Gini coefficient as a surrogate for the regulability or homeostasis of metabolite concentrations: focus on ergothioneine. Metabolomics, 22(5), Article 151. https://doi.org/10.1007/s11306-026-02534-1

Image Credits: AI Generated

DOI: 10.1007/s11306-026-02534-1

Keywords: Gini coefficient, metabolomics, ergothioneine, homeostasis, metabolite regulation, nutraceutical, pre-eclampsia, mass spectrometry, amino acids, vitamins, dietary antioxidants, health inequality

The research team, led by Jing Pan and Tzu-Shao Yeh of the Department of Nutrition and Food Hygiene at Nantong University in China, together with Luthfia Dewi of Universitas Muhammadiyah Semarang in Indonesia, focused their experiments on C2C12 cells, a widely used mouse skeletal muscle cell line that recapitulates key stages of muscle formation. These cells can be induced to behave like satellite cells, the resident stem cells of skeletal muscle, and to progress through the full differentiation program that turns undifferentiated myoblasts into mature, multinucleated myotubes, the cellular equivalent of muscle fibers. By treating these cells with boswellic acid and measuring changes at both the RNA and protein levels, the investigators were able to map the compound’s effects across the entire myogenic cascade.

The results were striking at multiple points along this cascade. Boswellic acid treatment produced a 17 percent increase in the number of Pax7-positive cells. Pax7 is the canonical marker of satellite cell identity and quiescent muscle stemness, and an expanded Pax7-positive population suggests that the compound preserves or expands the pool of cells capable of regenerating damaged or aging muscle tissue. This is a critical finding for the muscle aging field, because one hallmark of aged muscle is the depletion and dysfunction of its satellite cell reserve, leaving old muscles increasingly unable to repair themselves after injury, disuse, or disease.

Beyond stemness, the compound appeared to push cells more rapidly through the commitment and differentiation stages of muscle formation. The researchers quantified the relative messenger RNA levels of four master regulators of myogenesis: Pax7, Myf5, MyoD, and MyoG. These myogenic regulatory factors act in a choreographed sequence, with Pax7 maintaining the stem cell state, Myf5 and MyoD committing cells to the muscle lineage, and myogenin driving terminal differentiation and fusion into myotubes. Following boswellic acid treatment, the mRNA and protein levels of Myf5, MyoD, and MyoG were all significantly upregulated, indicating that the treated cells were accelerating through the myogenic differentiation program. The study also documented a two to four hour advancement in the myoblast renewal cycle, suggesting that the compound speeds the temporal rhythm by which muscle precursor cells proliferate and renew themselves before differentiating.

Protein-level confirmation came from Western blotting, a technique that separates proteins by molecular weight and detects them with specific antibodies. The team measured protein expression of Pax7, Myf5, MyoD, and MyoG, alongside loading controls such as beta-actin and GAPDH, and found the upregulation observed at the RNA level faithfully mirrored at the protein level. Immunofluorescence staining was used to visualize Pax7 and MyoD expression within individual cells, providing spatial confirmation that the molecular changes translated into shifts in the cellular populations themselves. Cell viability was assessed with the XTT assay, ensuring that the observed pro-myogenic effects were not simply an artifact of compound toxicity or stress-induced changes in cell behavior.

Perhaps the most translationally intriguing results concern hypertrophy, the enlargement of existing muscle fibers. Boswellic acid treatment significantly enhanced myotube hypertrophy through activation of the canonical hypertrophic signaling axis: the Akt-mTOR-p70S6K pathway. This pathway is the central growth-control circuit of skeletal muscle, integrating signals from insulin-like growth factor 1, mechanical loading, and nutrient availability to drive protein synthesis. Akt, or protein kinase B, phosphorylates and regulates downstream targets including mTOR, the mammalian target of rapamycin, which in turn activates p70S6K, a ribosomal protein S6 kinase that promotes ribosomal biogenesis and translation of muscle proteins. The researchers observed increased phosphorylation of all three nodes, indicating that boswellic acid switches on the same anabolic program engaged by resistance exercise and IGF-1 signaling.

The convergence of two effects, expanded stem cell activity and heightened anabolic signaling, is what distinguishes this study from many single-mechanism nutraceutical investigations. Aging muscle fails on both fronts: satellite cells become less numerous and less responsive, and the Akt-mTOR axis becomes progressively resistant to the anabolic stimuli of food intake and exercise, a phenomenon sometimes called anabolic resistance. A compound that simultaneously supports the regenerative stem cell compartment and re-energizes protein synthesis signaling could, in principle, address both dimensions of sarcopenia. The authors suggest that boswellic acid warrants consideration as a nutraceutical agent to enhance muscle differentiation and hypertrophy, and as a potential novel therapeutic strategy for mitigating muscle aging.

Boswellic acid itself has a long pharmacological history. It is the principal bioactive component of frankincense, the resin of Boswellia serrata and related species, and has been studied extensively for its anti-inflammatory properties, particularly its inhibition of 5-lipoxygenase and its effects on inflammatory pathways relevant to arthritis and inflammatory bowel disease. This new study extends its potential repertoire into muscle biology, a domain more commonly occupied by compounds such as creatine, leucine, and other branched-chain amino acids, and by pharmaceutical agents under development for sarcopenia. The triterpenoid structure of boswellic acid allows it to interact with multiple signaling proteins, which may explain its pleiotropic effects across the myogenic program and the growth-factor cascade.

The authors are careful to frame the work within its in vitro limits. All experiments were conducted in murine cell cultures, and the physiological concentration, absorption, and tissue distribution of boswellic acid in living organisms remain open questions. Satellite cell behavior in aged muscle is shaped by a complex niche of inflammatory signals, extracellular matrix changes, and vascular decline that a simplified cell culture cannot fully reproduce. The researchers explicitly state that additional in vivo and clinical investigations are warranted before any therapeutic relevance can be established. Human trials would need to establish safe dosing, bioavailability, and whether oral supplementation can achieve tissue concentrations capable of activating the pathways observed in culture.

Even so, the study adds to a growing scientific effort to identify accessible dietary compounds that can bias the balance between muscle loss and muscle regeneration in favor of renewal. With sarcopenia estimated to affect a substantial share of adults over sixty and to drive frailty, falls, and loss of independence, the search for safe, well-tolerated interventions is intensifying. If future animal and human studies confirm the mechanisms reported here, boswellic acid, a molecule that humans have consumed for millennia in the form of frankincense, could emerge as an unusually well-characterized candidate for supporting muscle health across the lifespan. For now, the finding stands as a compelling proof of concept: an ancient resin component, examined with modern molecular tools, appears capable of speaking the native language of regenerating muscle.

Subject of Research: Effects of boswellic acid on myogenic and hypertrophic signaling in skeletal muscle cells as a potential strategy against muscle aging

Article Title: Boswellic acid modulates myogenic and hypertrophic signaling in vitro: implications for muscle aging

Article References: Pan, J., Dewi, L., & Yeh, T.-S. (2026). Boswellic acid modulates myogenic and hypertrophic signaling in vitro: implications for muscle aging. BMC Complementary Medicine and Therapies. https://doi.org/10.1186/s12906-026-05596-9

Image Credits: AI Generated

DOI: 10.1186/s12906-026-05596-9

Keywords: boswellic acid, satellite cells, sarcopenia, muscle aging, myogenesis, skeletal muscle hypertrophy, Akt-mTOR-p70S6K, myogenic regulatory factors, nutraceutical, C2C12 cells, muscle regeneration, frankincense